Piramal Pharma
Peter DeYoung is the current CEO, Global Pharma at Piramal Pharma Limited, overseeing Piramal Pharma Solutions and Piramal Critical Care. With a background in private equity and consulting, Peter has held various leadership roles in the pharmaceutical industry. DeYoung holds an MBA from Stanford University Graduate School of Business and a BSE in Computer Science from Princeton University.